Skip to main content
. 2023 Mar 9;114(5):2063–2077. doi: 10.1111/cas.15743

TABLE 2.

Univariate analysis of 5‐year overall survival of hepatocellular carcinoma cases by Cox proportional hazards model

Parameters Number HR 95% CI p value
General background
Age (≥60 years/<60 years) 351/61 1.57 0.99–2.48 0.055
Sex (male/female) 351/61 0.75 0.50–1.13 0.172
Hepatitis virus infection (HB, HC/non‐B non‐C) 160/252 1.11 0.80–1.52 0.542
Child–Pugh classification (B/A) 14/398 1.39 0.65–2.96 0.397
Tumor factor
Tumor number (>2/1) 134/278 2.24 1.65–3.04 <0.0001
Tumor size (≥5 cm/<5 cm) 176/236 1.97 1.45–2.67 <0.0001
Histology (poor/well or moderate) 61/351 1.23 0.81–1.85 0.329
Lymph node metastasis (positive/negative) 4/408 10.41 3.76–28.79 <0.0001
Vascular invasion (positive/negative) 155/257 2.24 1.65–3.03 <0.0001
Capsular formation (positive/negative) 351/59 0.85 0.56–1.28 0.430
Capsular invasion (positive/negative) 284/123 1.02 0.73–1.43 0.893
UICC stage (IIIA–IVA/IA–II) 113/299 2.51 1.84–3.44 <0.0001
DKK1/CKAP4 expression
DKK1+/CKAP4+ vs. DKK1 − CKAP4− 55/159 3.39 2.21–5.20 <0.0001
DKK1+/CKAP4+ vs. DKK1 + CKAP4− 55/162 3.94 2.54–6.11 <0.0001
DKK1+/CKAP4+ vs. DKK1−CKAP4+ 55/36 4.64 2.29–9.40 <0.0001

Note: p values ≤0.05 are statistically significant.

Abbreviations: CI, confidence interval; CKAP4, cytoskeleton‐associated protein 4; DKK1, Dickkopf‐1; HB, hepatitis B; HC, hepatitis C; HCC, hepatocellular carcinoma; non‐B non‐C, non‐hepatitis B and non‐hepatitis C; HR, hazard ratio.